SpacthatAsk Monday, 03/04/19 10:29:47 PM Re: None Post # of 39 Will Quadron follow in Valeans footsteps? For me this comes down to if QCC is the next VGW (Valeans)...I do like Rosy (CEO) and Quadron and see it as a potential buyout option for junior LPs that need and want to get into the extraction business. The market cap here isn't that high considering the potential, but I find most "potential" based valuations in the sector aren't really getting respected by an increase to the SP. If Quadron slips at all from $0.18 I'm buying more. The recent NRs make it seem like people are exploring their options and they do like the plug-and-play BOSS system over the higher cost options out there. Most mid to smaller LPs don't want to hand this stuff off to a processor, they simply intend to integrate a smaller extraction operation into their company for the benefit of producing items that will eventually be for sale in Canada's legal cannabis system. I would like to see Quadron contracted by an LP to handle their extraction needs, that would give me a better vibe around QCC, but when Valeans got their license, and then Canopy and Organigram it just took off. Here we are look at RTI same thing today 41% day on the back of getting their license. Anyone know where Quadron is in seeking a license to have their own extraction facilities licensed with Health Canada? Also like the Quadron vape pen skews currently selling in the cali market, could interest potential buyers down the line as well. Vape pens will be a massive market once they're legal in Canada.